iCliniq Logo
HomeAnswersGeneral Medicineneurofibromatosis

How can NF1 be managed in children?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

My six-year-old nephew was diagnosed with NF1 after several cafe-au-lait spots were noticed, and genetic testing confirmed the diagnosis. Since then, he has started developing small lumps on his skin and has been having trouble focusing at school. His parents are concerned that this could affect his learning or lead to serious tumors in the future. They have been referred to a neurologist, but the situation is overwhelming. Are there any specialized therapies or support services he should be receiving right now?

Is it common for NF1 to impact children’s development or cause pain? We want to stay ahead of this, but we're unsure where to start.

Please help.

Hello,

Welcome to icliniq.com.

I understand your concern.

I have reviewed your query and understand your concern.

Neurofibromatosis type 1 (NF1) is a genetic condition that causes changes in skin pigmentation and the development of tumors on nerve tissue. The skin changes typically include flat, light brown spots and freckles, particularly in the armpits and groin. Tumors can form anywhere in the nervous system, including the brain, spinal cord, and nerves. NF1 is relatively rare, affecting about one in 2,500 individuals. Most children with NF1 experience mild symptoms that do not significantly limit their daily activities.

While there is no cure for NF1, treatments are available to help manage symptoms and improve quality of life. Children with NF1 are typically cared for by a team of specialists, including neurologists to address issues related to the nerves, brain, and spinal cord, and plastic surgeons to manage appearance concerns.

Treatment options for NF1:

  1. Vitamin D and calcium supplementation: To decrease the risk of osteoporosis.
  2. Bisphosphonate treatment: May be helpful for some children.
  3. Targeted therapy: MEK (mitogen-activated protein kinase) inhibitors, such as Selumetinib or Mirdametinib, can reduce the size and symptoms of inoperable plexiform neurofibromas in many individuals with NF1.

I hope this helps answer your questions.

Thank you for using iCliniq, and I hope you have a great day.

Medically reviewed byiCliniq medical review team

Published At July 16, 2025
Reviewed AtJuly 18, 2025

Same symptoms don't mean you have the same problem. Consult a doctor now!

Listen to related tracks in our music library

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.